Our recent highlights
Key facts and figures from 2024 including UCB Australia data
>3.1 million people
have accessed our solutions*
In 2023, over 70,000 Australians benefitted from UCB medicines§
36 country affiliates
with Belgium headquarters
UCB Australia Pty Ltd was registered in 2000
Over 9000 UCB employees worldwide
Including over 80 in Australia
29% R&D/revenue ratio
invested into new medicine breakthroughs#
9 molecules
in clinical development#
With 68 clinical trials of UCB medicines conducted in Australia, 29 of those studies include children†
#2 in Pharma Innovation
UCB recognized by FirstWord Pharma in 2023 global rankings‡
*2024 patient numbers are calculated using the Moving Annual Total (MAT) patients (Estimated Actual Treated) at the end of Q3 2024 as provided with input data from an external source. The total patient number gathers people who have accessed 9 UCB medicines. §UCB Australia data on file. #As of December 2024. †Source: https://clinicaltrials.gov (accessed 27th August 2024). ‡Source: https://firstwordpharma.com/story/5818272.
AU-OT-2400043. May 2025.